StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
vTv Therapeutics Trading Up 2.6 %
VTVT stock opened at $0.74 on Tuesday. The stock has a 50-day moving average price of $0.74 and a 200-day moving average price of $0.79. vTv Therapeutics has a 1-year low of $0.63 and a 1-year high of $1.40. The firm has a market cap of $77.39 million, a PE ratio of -3.08 and a beta of -1.19.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Prudential Financial Inc. acquired a new stake in shares of vTv Therapeutics in the 2nd quarter valued at about $30,000. HBK Sorce Advisory LLC acquired a new stake in shares of vTv Therapeutics in the 4th quarter valued at about $38,000. Millennium Management LLC grew its stake in shares of vTv Therapeutics by 12.0% in the 2nd quarter. Millennium Management LLC now owns 138,683 shares of the biotechnology company’s stock valued at $104,000 after buying an additional 14,845 shares during the period. Finally, State Street Corp grew its stake in shares of vTv Therapeutics by 268.7% in the 2nd quarter. State Street Corp now owns 206,145 shares of the biotechnology company’s stock valued at $155,000 after buying an additional 150,228 shares during the period. 3.41% of the stock is owned by institutional investors.
About vTv Therapeutics
vTv Therapeutics Inc, a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company's lead drug candidate is TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis.
See Also
- Five stocks we like better than vTv Therapeutics
- What Are Dividend Achievers? An Introduction
- 3 Sizzling Dividends That Are Going On Sale
- How to Analyze Restaurant Stocks
- 3 Ways To Trade, Trade Desk Stock Post Earnings
- What Are Meme Stocks and Are They Viable Investments?
- Inflation, The Fed, and Oil Prices: Interest Rates Are Going Up
Receive News & Ratings for vTv Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for vTv Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
